Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population

1. De Laurentiis, M.
2. Borstnar, S.
3. Campone, M.
4. Warner, E.
5. Bofill, J.S.
6. Jacot, W.
7. Dent, S.
8. Martin, M.
9. Ring, A.
10. Cottu, P.
11. Lu, J.
12. Ciruelos, E.
13. Azim, H.A.
14. Chatterjee, S.
15. Zhou, K.
16. Wu, J.
17. Menon-Singh, L.
18. Zamagni, C.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1007/S10549-021-06334-0 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus